Form 4: Concentra Group Holdings Executive Receives Stock Grant
SEC Form 4 Filing
John Robert Anderson Jr., an executive at Concentra Group Holdings, received a grant of 60,000 shares of restricted stock.
Summary
- John Robert Anderson Jr., Executive Vice President and Chief Medical Officer at Concentra Group Holdings Parent, Inc., was granted 60,000 shares of restricted common stock on November 26, 2024.
- The stock grant will vest in equal annual installments over four years.
- This transaction was reported in a Form 4 filing with the SEC.
- The filing also includes a Limited Power of Attorney document, dated October 25, 2024, authorizing Timothy F. Ryan to act on behalf of John Robert Anderson Jr. for Section 16 reporting obligations.
Sentiment
Score: 7
Explanation: The document reflects a routine executive compensation event, which is generally positive for aligning management and shareholder interests. There are no negative implications.
Positives
- The stock grant could serve as an incentive for the executive to perform well.
- The vesting schedule encourages long-term commitment from the executive.
Industry Context
Stock grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.
Comparison to Industry Standards
- Stock grants are a standard practice for executive compensation across various industries.
- The four-year vesting schedule is also a common practice to ensure long-term alignment of interests.
- Companies like UnitedHealth Group and Cigna, which operate in similar healthcare services sectors, also use stock grants as part of their executive compensation packages.
Stakeholder Impact
- The stock grant may positively impact shareholder confidence by aligning executive interests with company performance.
- The grant could motivate the executive to contribute to the company's success.
Key Dates
| Date | Description |
|---|---|
| 2024-10-24 | Date of acknowledgement of the Limited Power of Attorney. |
| 2024-10-25 | Date of execution of the Limited Power of Attorney. |
| 2024-11-26 | Date of the stock grant transaction. |
| 2024-11-29 | Date of signature of the Form 4 filing. |
Keywords
stock grant, restricted stock, executive compensation, Form 4, SEC filing, Concentra Group Holdings, insider trading, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.